Examining Change Mechanisms in Psychotherapy (CAMP)

April 11, 2018 updated by: Modum Bad

Examining Change Mechanisms in Psychotherapy: Relationship Between Specific Ingredients and Common Factors in Promoting Change.

This research project seeks to acquire a deeper understanding of the complex influences of common factors and specific ingredients in psychotherapy. By using frequent process-outcome measures, it will address individualized mechanisms of change in psychotherapy by assessing both between and within patient change processes, using a wide spectrum of change indicators.

Study Overview

Detailed Description

The study is a naturalistic study conducted by collecting data from in-patient units at Modum Bad (psychiatric hospital). The sample includes different patient groups with a variety of psychological disorders. Further, sample is gathered from units using different treatment approaches (short-term psychodynamic treatment, cognitive-behavioral treatment, metacognitive therapy, compassion-focused therapy, relational psychodynamic therapy, existential therapy and stabilizing trauma-therapy).

The following specific research questions will be explored:

  1. The role of common factors:

    1. What are the relative influences of different common factors such as agreement on task and goals, treatment credibility and 'the real relationship', across treatments and diagnoses?
    2. Do some common factor variables stand out regarding ability to explain variance in outcome and across outcomes?
    3. Do measures of common factors have a consistent effect on outcome across treatment models and diagnoses, or does the explanatory value of common factors vary across diagnose and treatment model?
  2. The role of specific change mechanisms (affective, cognitive and meta-cognitive):

    1. To what extent do specific change mechanisms predict change in various outcome domains?
    2. Are these specific change mechanisms equally important predictors, or do they vary across treatment or diagnose?
  3. Are there interaction effects between common factors and specific factors across treatment models, patient diagnoses and outcome domain?

Self-report data will be collected three times a week on mechanisms of change and symptoms, established by psychotherapy theory and research evidence as important for psychological change. The data collection consists of three different forms administered once per week on different days. The forms are separated by topic; symptoms, contextual factors, and change processes. The questions in the forms are selected from short instruments with good psychometric qualities. The data collection procedure has at present been tested on five patient cohorts with good results.

Study Type

Observational

Enrollment (Anticipated)

520

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ingvild Finsrud, Master degree
  • Phone Number: 0047 95899278
  • Email: ingvilfi@gmail.com

Study Locations

    • Buskerud
      • Vikersund, Buskerud, Norway, 3370
        • Recruiting
        • Modum Bad
        • Contact:
        • Principal Investigator:
          • Ingvild Finsrud, Master

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients accepted for inpatient treatment at Modum Bad Psychiatric hospital during the time of data collection will participate in this study, contingent on consent.

The patients included will be all genders, adults and reciving treatment from specialist health care.

Description

Inclusion Criteria:

  • Must be a patient at Modum Bad
  • Have a psychological disorder
  • Must have rights to treatment according to the rules of specialist health care in Norway. Includes the following:

    1. Patient is expected to have poorer prognosis of life quality if not given treatment
    2. It is expected that the patient will benefit from treatment
    3. It is expected that there is a reasonable cost-effect balance regarding the treatment given and the patient's benefit from treatment.

Exclusion Criteria:

  • Acute suicidality
  • Ongoing/active abuse of harmful drug(s)
  • Under 18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Anxiety unit
Patients have anxiety as a primary diagnose. Receive treatment for anxiety (CBT and MCT).
There are different psychotherapy models offered across the units. All patients receive individual treatment and group therapy or psychoeducative groups.
Eating disorder unit
Patients have eating disorder as primary diagnose. Receive treatment for their eating disorder (CBT and compassion-focused therapy).
There are different psychotherapy models offered across the units. All patients receive individual treatment and group therapy or psychoeducative groups.
Depression unit
Patients have depression as primary disorder. Receive treatment for their depression (Short-term dynamic therapy, existential therapy and relational psychodynamic therapy).
There are different psychotherapy models offered across the units. All patients receive individual treatment and group therapy or psychoeducative groups.
Family unit
One of the members of the family has a psychological disorder. The treatment is focused towards the family and family dynamics.
There are different psychotherapy models offered across the units. All patients receive individual treatment and group therapy or psychoeducative groups.
Trauma unit
Patients have PTSD and relational trauma as primary diagnosis. Receive stabilizing treatment and exposure therapy.
There are different psychotherapy models offered across the units. All patients receive individual treatment and group therapy or psychoeducative groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptom checklist revised (SCL-90-R)
Time Frame: Change measure (baseline, 14 weeks, and 12 months).
A general measure of symptoms distress
Change measure (baseline, 14 weeks, and 12 months).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inventory of interpersonal problems
Time Frame: Change measure (baseline, 14 weeks, and 12 months).
Self-report questionnaire of interpersonal problems
Change measure (baseline, 14 weeks, and 12 months).
Beck's depression inventory
Time Frame: Change measure (baseline, 14 weeks, and 12 months).
Measure of depressive symptoms
Change measure (baseline, 14 weeks, and 12 months).
PTSD checklist for Diagnostic and Statistical Manual 5 (PCL-5)
Time Frame: Change measure (baseline, 14 weeks, and 12 months).
PTSD symptom measure
Change measure (baseline, 14 weeks, and 12 months).
M-POQ outcome, anxiety
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
Measures anxiety symptoms
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
M-POQ outcome, depression
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
Measures depression symptoms
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
M-POQ outcome, loneliness
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
Measures experienced loneliness
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
M-POQ outcome, resilience
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
Measures experienced recilience
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
M-POQ outcome, well-being
Time Frame: Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).
Measures experienced well-being
Change measure (baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 11 weeks, 12 weeks, 13 weeks and 14 weeks).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2017

Primary Completion (Anticipated)

August 20, 2020

Study Completion (Anticipated)

August 20, 2021

Study Registration Dates

First Submitted

January 25, 2018

First Submitted That Met QC Criteria

April 11, 2018

First Posted (Actual)

April 20, 2018

Study Record Updates

Last Update Posted (Actual)

April 20, 2018

Last Update Submitted That Met QC Criteria

April 11, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Psychotherapy

3
Subscribe